Breaking News Instant updates and real-time market news.

CARO

Carolina Financial

$33.18 /

+0.2 (+0.61%)

07:36
08/29/19
08/29
07:36
08/29/19
07:36

Carolina Financial upgraded to Strong Buy, shares attrative, says Raymond James

As previously reported, Raymond James upgraded Carolina Financial to Strong Buy from Outperform and maintained a $39 price target. Analyst William Wallace believes Carolina's margin picture is "less gloomy" than pears and has less pressure on loan yields than most. Further, the Mortgage Company segment should exceed expectations in a falling rate environment, offsetting spread revenue pressures, the analyst wrote in a note to investors. Wallace views risk/reward as "very attractive" given above peer profitability.

  • 23

    Sep

  • 13

    Nov

CARO Carolina Financial
$33.18 /

+0.2 (+0.61%)

10/26/18 BMUR
Carolina Financial price target lowered to $41 from $46 at Brean Capital
04/26/19 SDLR
Carolina Financial downgraded to Hold from Buy at Sandler O'Neill
04/26/19 SDLR
Carolina Financial downgraded to Hold following run-up at Sandler O'Neill
08/29/19 RAJA
Carolina Financial upgraded to Strong Buy from Outperform at Raymond James

TODAY'S FREE FLY STORIES

On The Fly
Piper lists 10 strategic M&A opportunities for Microsoft in 'defining' 2020 » 14:19
01/23/20
01/23
14:19
01/23/20
14:19
MSFT

Microsoft

$166.14 /

+0.44 (+0.27%)

, TWLO

Twilio

$120.89 /

+1.8 (+1.51%)

, WDAY

Workday

$184.00 /

+1.42 (+0.78%)

, CRM

Salesforce

$183.39 /

+0.67 (+0.37%)

, RNG

RingCentral

$197.85 /

+2.68 (+1.37%)

, ZEN

Zendesk

$86.21 /

+0.975 (+1.14%)

, COUP

Coupa Software

$164.92 /

-2.57 (-1.53%)

In a research note to…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Fly Intel: What to watch in credit card space earnings reports » 14:18
01/23/20
01/23
14:18
01/23/20
14:18
AXP

American Express

$131.19 /

-0.37 (-0.28%)

, V

Visa

$206.88 /

-1 (-0.48%)

, MA

MasterCard

$323.60 /

-0.8 (-0.25%)

American Express (AXP),…

American Express (AXP), MasterCard (MA), and Visa (V) are scheduled to report quarterly results on January 24, 29, and 30, respectively. What to watch for: 1. OUTLOOKS: During the company's last earnings call, American Express said it sees fourth quarter revenue growth up 8%-10%, and backed fiscal year 2019 adjusted earnings per share view of $7.85-$8.35, with consensus at $8.12. The company also said it sees double-digit earnings per share growth in fiscal year 2019, fiscal year 2020 adjusted earnings per share growth in the mid-teens, and fiscal year 2020 revenue growth low double digits. Meanwhile, back in October, MasterCard said it sees fiscal year 2019 revenue growth at "high end of low teens," fiscal year 2019 tax rate of approximately 18%, fiscal year 2019 adjusted OpEx growth in the "high end of single-digits," and fourth quarter adjusted OpEx growth in the "high single-digits." 2. FTC INVESTIGATION: In a regulatory filing, Visa confirmed that on November 4, 2019, the Bureau of Competition of the United States Federal Trade Commission requested that Visa provide, on a voluntary basis, documents and information for an investigation as to whether Visa's actions inhibited merchant choice in the selection of debit payments networks in potential violation of the Durbin Amendment to the Dodd-Frank Wall Street Reform and Consumer Protection Act. According to a report by Bloomberg, both Visa and MasterCard have drawn an inquiry by U.S. antitrust regulators over policies that can prohibit merchants from routing card transactions over alternative debit networks. At issue is whether the card companies and big debit card issuers are blocking retailers from routing certain mobile wallet payments and tap-to-pay transactions over alternative networks such as Pulse, NYCE and Star, sources told Bloomberg. 3. PLAID ACQUISITION: Last week, Visa announced it has signed a definitive agreement to acquire Plaid, for a total purchase consideration of $5.3B. The transaction is subject to regulatory approvals and other customary closing conditions. Visa will fund the transaction from cash on hand and debt issuance at the appropriate time. This transaction will have no impact on Visa's previously announced stock buyback program or dividend policy. The transaction is expected to close in the next three to six months. 4. DIVIDEND INCREASE: Mastercard announced late last year that its board had declared a quarterly cash dividend of 40c per share, a 21% increase over the previous dividend of 33c per share. The cash dividend will be paid on February 7, 2020 to holders of record of its Class A common stock and Class B common stock as of January 9, 2020. The board also approved a new share repurchase program, authorizing the company to repurchase up to $8B of its Class A common stock. The new share repurchase program will become effective at the completion of the company's previously announced $6.5B program. The company has approximately $300M remaining under the current program authorization. 5. ATTRACTIVE VALUATION: In a research note to investors last week, William Blair analyst Robert Napoli reiterated an Outperform rating on American Express after reviewing the company's monthly data and trends in retail sales. The analyst believes valuation for the stock is "attractive given outlook and relative metrics to S&P 500." While some investors seem concerned about 2020 guidance, Napoli noted that management is confident in its outlook for 8%-10% revenue growth and double-digit EPS growth in 2020.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 14:17
01/23/20
01/23
14:17
01/23/20
14:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NYSE market internals summary » 14:16
01/23/20
01/23
14:16
01/23/20
14:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
Regeneron tells Bloomberg to apply technologies to new coronavirus » 14:14
01/23/20
01/23
14:14
01/23/20
14:14
REGN

Regeneron

$357.08 /

-2.1 (-0.58%)

A Regeneron spokeswoman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD » 14:10
01/23/20
01/23
14:10
01/23/20
14:10

FX Action: USD-CAD eased…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Stifel says continues to recommend buying Netflix shares on pullbacks » 14:08
01/23/20
01/23
14:08
01/23/20
14:08
NFLX

Netflix

$341.73 /

+15.68 (+4.81%)

, CMCSA

Comcast

$45.75 /

-1.75 (-3.68%)

, CMCSK

Comcast

$0.00 /

+ (+0.00%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Whiting Petroleum call volume above normal and directionally bullish » 14:05
01/23/20
01/23
14:05
01/23/20
14:05
WLL

Whiting Petroleum

$4.98 /

-0.095 (-1.87%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
HP says value creation not dependent on Xerox deal, blames Icahn for nominees » 14:01
01/23/20
01/23
14:01
01/23/20
14:01
HPQ

HP Inc.

$22.13 /

+0.2 (+0.91%)

, XRX

Xerox

$36.31 /

+ (+0.00%)

HP Inc. (HPQ) confirmed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Wells Fargo to determine if further action appropriate after OCC actions » 13:58
01/23/20
01/23
13:58
01/23/20
13:58
WFC

Wells Fargo

$48.32 /

-0.25 (-0.51%)

In response to actions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
HP says Xerox buyout proposal 'significantly undervalues' company  13:57
01/23/20
01/23
13:57
01/23/20
13:57
HPQ

HP Inc.

$22.11 /

+0.185 (+0.84%)

, XRX

Xerox

$36.27 /

-0.04 (-0.11%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
HP says Xerox board nominations 'self-serving tactic'  13:56
01/23/20
01/23
13:56
01/23/20
13:56
HPQ

HP Inc.

$22.11 /

+0.185 (+0.84%)

, XRX

Xerox

$36.27 /

-0.04 (-0.11%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Blue Prism price target raised to 2,000 GBp from 1,710 GBp at Jefferies » 13:55
01/23/20
01/23
13:55
01/23/20
13:55
BPRMF

Blue Prism Group

$0.00 /

+ (+0.00%)

Jefferies analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: » 13:55
01/23/20
01/23
13:55
01/23/20
13:55

FX Action: USD-JPY fell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
DOJ requires ZF, Wabco to divest Wabco steering components unit to complete deal » 13:53
01/23/20
01/23
13:53
01/23/20
13:53
WBC

Wabco

$135.51 /

+0.12 (+0.09%)

The Department of Justice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
NIAID developing Gilead's remdesivir as coronavirus antiviral, Bloomberg says » 13:48
01/23/20
01/23
13:48
01/23/20
13:48
GILD

Gilead

$63.44 /

-0.06 (-0.09%)

A possible vaccine to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
FDA highlights cybersecurity vulnerabilities in certain GE telemetry servers » 13:48
01/23/20
01/23
13:48
01/23/20
13:48
GE

General Electric

$11.69 /

+0.31 (+2.73%)

The Food and Drug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Karuna pullback on PureTech sale a buying opportunity, says Wells Fargo » 13:45
01/23/20
01/23
13:45
01/23/20
13:45
KRTX

Karuna Therapeutics

$98.59 /

-17.38 (-14.99%)

Wells Fargo analyst Jacob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23
    Jan
Options
Novavax call volume above normal and directionally bullish » 13:45
01/23/20
01/23
13:45
01/23/20
13:45
NVAX

Novavax

$7.66 /

+0.58 (+8.19%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
NBC to produce four daily Tokyo 2020 Olympics shows for Snapchat, Variety says » 13:40
01/23/20
01/23
13:40
01/23/20
13:40
SNAP

Snap

$19.27 /

+0.19 (+1.00%)

Variety's Todd…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Gilead assessing Ebola drug as potential coronavirus treatment, Bloomberg says  13:36
01/23/20
01/23
13:36
01/23/20
13:36
GILD

Gilead

$63.16 /

-0.34 (-0.54%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
New Residential put volume heavy and directionally bearish » 13:35
01/23/20
01/23
13:35
01/23/20
13:35
NRZ

New Residential

$16.62 /

-0.1 (-0.60%)

Bearish flow noted in New…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Peoples Bancorp reports Q4 EPS 50c vs. 57c a year ago » 13:32
01/23/20
01/23
13:32
01/23/20
13:32
PEBK

Peoples Bancorp

$30.45 /

+ (+0.00%)

Lance Sellers, President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Fly Intel: What to watch in Intuitive Surgical earnings report » 13:31
01/23/20
01/23
13:31
01/23/20
13:31
ISRG

Intuitive Surgical

$609.52 /

-0.71 (-0.12%)

, MDT

Medtronic

$120.21 /

-0.92 (-0.76%)

, TRXC

TransEnterix

$1.40 /

-0.03 (-2.10%)

, JNJ

Johnson & Johnson

$147.54 /

-0.73 (-0.49%)

Intuitive Surgical (ISRG)…

Intuitive Surgical (ISRG) is scheduled to report the results of its fourth fiscal quarter after the market close on Thursday, January 23, with a conference call scheduled for 4:30 pm EDT. What to watch: 1. PROCEDURAL GROWTH: Along with its third quarter report in October, Intuitive Surgical expanded its FY19 procedure growth view to 17%-18% from 16%-17%. U.S. general surgery procedures and worldwide urologic procedures were the catalysts to an increase of Worldwide da Vinci procedures growth of approximately 20% in Q3. "Intuitive's performance in our second quarter was solid. Our teams remain focused on helping our customers improve outcomes and lower the total cost to treat per patient episode for their patient populations," said Intuitive CEO Gary Guthart. 2. PRELIMINARY RESULTS: On January 9, Intuitive reported preliminary Q4 results ahead of its participation at the 38th Annual JP Morgan Healthcare Conference. According to the company, worldwide da Vinci procedures increased by approximately 19% in Q4 compared with Q4 of 2018. FY19 worldwide da Vinci procedures increased by approximately 18% compared with FY18. Preliminary Q4 revenue of $1.278B grew 22% compared with $1.047B for Q418. Preliminary 2019 revenue of $4.479B grew 20% compared with $3.724B for 2018. Analysts had been projecting that that Intuitive would report revenue of $1.22B. 3. CORPORATE DEVELOPMENTS: In 2019, The FDA approved Intuitive's Ion endoluminal system to enable minimally invasive biopsy in the peripheral lung. Additionally, this past December, reports indicated that Congress would move to permanently repeal three major health industry taxes that were originally implemented to help pay for "Obamacare." Congressional lawmakers have agreed to repeal the "Cadillac tax" on expensive employer plans, repeal a tax on medical devices and repeal a health insurance fee. In Late November, Intuitive announced FDA clearance of two innovative technologies for two of the company's da Vinci surgical systems to help improve procedures that require sealing. 4. COMPETITION: Intuitive is facing competitive threats from Medtronic (MDT), Transenterix (TRXC), and Johnson & Johnson (JNJ), which acquired Auris Health in 2019, and whose Monarch platform is used for diagnostic and therapeutic bronchoscopic procedures.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Peoples Bancorp declares 15c per share special cash dividend » 13:30
01/23/20
01/23
13:30
01/23/20
13:30
PEBK

Peoples Bancorp

$30.45 /

+ (+0.00%)

Peoples Bancorp's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.